ClinicalTrials.gg
SupplementDrug

Resveratrol clinical trials

Also written resVida and BIA 6-512.

studies test it
133
open now
9
in phase 3
11
first study started
2004

How each study uses Resveratrol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Resveratrol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Resveratrol
94
Trans-resveratrol
13
Veri-teTM Resveratrol
2
resVida (99% pure trans-resveratrol) provided by DSM Nutritional Products, Ltd.
2
Trans- resveratrol
2

Development codes

BIA 6-512
3
SRT501
1
JNS115
1

Other names

resVida
5

Studies by the year they started

133 studies that test it; most in 2011 (13)

Studies that test Resveratrol, by start year
YearStudies
20043
20053
20064
20071
20085
20097
20104
201113
201212
20139
20149
201511
20169
20172
20189
20197
20204
20215
20223
20233
20244
20253
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
22
Phase 2
32
Phase 3
11
Phase 4
4
No phase
67

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 124

Northumbria University (9) · Bial - Portela C S.A. (7) · Maastricht University Medical Center (6) · University of Aarhus (5) · National Cancer Institute (NCI) (4) · Khyber Medical University Peshawar (3) · University of Florida (3) · InCor Heart Institute (3)

Often tested with

Tested in the same studies.

Curcumin (4) · Urtica dioica (2) · Ascorbic Acid (2) · Thioctic Acid (2) · Chenodeoxycholic Acid (1) · Atorvastatin (1) · Quercetin (1) · Concord grape juice (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Resveratrol.

Studies

Open first, then newest update. How each study uses Resveratrol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 133

See all 133 studies that test Resveratrol →

Given beside what is tested · 2 — Resveratrol is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Resveratrol

Codes

What other systems call Resveratrol · ClinicalTrials.gg INT006657

  • MeSH (NLM) D000077185ResveratrolConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) Q369O8926LRESVERATROLConfirmed FDA, NLM, Wikidata
  • RxNorm 1000492Confirmed FDA, Wikidata
  • Wikidata Q407329resveratrolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1215ResveratrolOne source FDA
  • DrugBank DB02709One source Wikidata

Also registered as resveratrol, (z)- (UNII AUA0K06FSB).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.